TB-500 Peptide Research Hub — Thymosin Beta-4 Tissue-Repair Studies
TB-500 is a synthetic peptide corresponding to the active region of naturally occurring Thymosin Beta-4 — one of the most abundant actin-sequestering proteins in mammalian cells. It is widely studied in tissue-repair, angiogenesis and cell-migration research.
What this hub covers
- Actin G-to-F sequestering mechanism
- Cell migration and endothelial proliferation literature
- Cardiac, dermal and corneal tissue-repair models
- Comparisons and synergy with BPC-157
- Reconstitution and storage for research use
TB-500 research articles
All research →Thymosin Beta-4 (TB-500) Research Overview
Thymosin Beta-4: actin sequestration, tissue repair, angiogenesis, and cardiac protection research — a complete mechanistic and evidence overview.
Read article →TB-500 Benefits and Side Effects: A Research Guide
Published benefits, side effects, and BPC-157 comparisons for TB-500 — the actin-sequestering Thymosin Beta-4 fragment used in tissue-repair research.
Read article →BPC-157 vs TB-500: Tissue Repair Research Comparison
Compare BPC-157 and TB-500 (thymosin beta-4 fragment) — two leading tissue-repair research peptides — across mechanism, half-life, and published findings.
Read article →BPC-157 Benefits and Side Effects: A Research Guide
A literature-grounded reference for BPC-157's reported mechanisms, benefits across preclinical tissue-repair models, and documented safety profile — for research use only.
Read article →What is BPC-157? A Research Primer
A comprehensive research primer on BPC-157 (Body Protection Compound-157) — a pentadecapeptide derived from human gastric juice. Covers origins, mechanism of action, tendon and gut healing research, angiogenesis, and CNS research findings.
Read article →TB-500 research FAQ
- What is TB-500?
- TB-500 is a synthetic peptide fragment of Thymosin Beta-4 (Tβ4), a 43-amino-acid actin-sequestering protein. The fragment retains the actin-binding region responsible for cell migration and tissue-repair signalling in the published literature.
- How does TB-500 differ from BPC-157?
- TB-500 acts via actin sequestration and cell migration; BPC-157 acts primarily through VEGFR2 and nitric-oxide-mediated angiogenesis. The two are commonly studied together for complementary mechanisms — see the BPC-157 vs TB-500 comparison.
- What models is TB-500 most cited in?
- Cardiac repair after ischaemia, corneal wound healing, dermal repair and skeletal muscle regeneration are among the most-cited models. The TB-500 research overview compiles representative citations.
- How is TB-500 stored?
- Lyophilized TB-500 is stable at 2–8 °C protected from light. After reconstitution with bacteriostatic water, refrigerate and use within the COA's documented window.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.